EyePoint to lay off 105 workers in Watertown and Northbridge

The layoffs, part of a companywide cut of about 53%, are scheduled from Dec. 31, 2026, to Jan. 31, 2027.
Loading coverage...
Coverage of biotech from Six State Signal.

The layoffs, part of a companywide cut of about 53%, are scheduled from Dec. 31, 2026, to Jan. 31, 2027.

Foghorn and Eli Lilly decided Sept. 25 not to move the experimental drug FHD-909 into the next stage of its trial. The biotech expects to have about 65 full-time employees once the cuts are substantially complete in the fourth quarter.

The cash awards for the CEO and chief legal officer come in stages. Their stock units are still to be granted and depend on milestones and continued service.

The biotech has not said how many jobs that is. It is dropping an add-on drug and shifting to a different combination.

The Watertown company said the reductions span departments after a review of staffing needs; no current workforce percentage was confirmed.